Longevitytech.fund make significant investment in Occuity

Updated: 6 days ago

Whilst our crowdfunding campaign on Seedrs continues to overfund, we are also in discussion with several angel investors and investment funds. As such we are delighted to announce that Longevitytech.fund is the latest investor to join Occuity on our journey to improve the lives of millions of people who suffer the long-term effects of chronic diseases.


Longevitytech.fund provides pre-seed and seed-stage investments in some of the best worldwide early-stage start-ups and spinoffs based on their close cooperation with top scientists in the field of aging research and rejuvenation, biotechnology, bioinformatics, agetech, and related AI. They take an active approach by providing entrepreneurial help, network and commercialization support. Commenting on the investment in Occuity Petr Sramek, Co-founder, Chairman and Managing Partner at Longevitytech.fund, said:


The goal of our fund is to extend healthy and active human life and minimize the impact of chronic and age-related diseases. Occuity’s novel patented optical technology fits our thesis very well, because we desperately need scalable and accessible diagnostic and monitoring technologies to better measure the onset and treatment of chronic and age-related diseases, as well as aging itself.

Occuity CEO, Dr. Dan Daly commented: “Petr helps innovative teams in Artificial Intelligence and Longevity technology grow into confident companies with global ambitions. I am confident that the advice and support provided by Petr and his team on fundraising, strategy, and product management will prove extremely valuable and we look forward to working with Longevitytech.fund as we continue to grow the business.”


On our Seedrs campaign, Dan commented:


This significant investment means that Occuity are now 146% overfunded. As we are in ongoing discussion with a number of other potentially significant investors, this does mean that the investment round may close earlier than previously anticipated.

We want to ensure anyone who has supported us along the way, by joining our community and pre-registering for our campaign, completes their investment before the round closes. If you want to find out more please visit our Seedrs campaign page – www.seedrs.com/occuity


Petr Sramek has been a serial entrepreneur for more than 33 years and believes that science and technology can help humanity reach a new, better level of being. He is building science, funding, and business infrastructure to support faster adoption of health-span improving technologies. He is a founder of Longevitytech.fund, former Entrepreneur in Residence at Singularity University, co-founder of the Longevityforum.eu, board member at Animal Biosciences (US), AgeCurve (UK), iamYiam (UK). He helps innovative teams in the Longevity sector grow into confident companies with global ambitions. He provides advice on fundraising, strategy, and product management. He advises companies as a mentor at Foresight Institute and On Deck Longevity Biotech.


Capital At Risk


53 views0 comments